This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Amo Groningen B.v.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Richard Henricus Christianus Eijmberts
Introduction
Richard Henricus Christianus Eijmberts is an accomplished inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of intraocular lens technology. His innovative approach has led to the development of a unique method for removing intraocular lenses from injection molded mold halves.
Latest Patents
Eijmberts holds a patent for a "Method and an assembly for removing an intraocular lens from an injection molded mold half." This patent describes a process where spill ring material is first removed from the mold half. The mold/lens assembly is then subjected to an oscillating mechanical load that does not substantially deform the part of the mold half in direct contact with the lens body. The oscillating mechanical load has a frequency that excites the mold/lens assembly to break the bonds between the intraocular lens and the mold half. Finally, a static mechanical push force is applied to the bottom side of the mold half to partially separate the intraocular lens from the mold half. Eijmberts has 1 patent to his name.
Career Highlights
Eijmberts is associated with Amo Groningen B.V., where he continues to innovate in the field of medical devices. His work has been instrumental in improving the efficiency and effectiveness of intraocular lens removal processes.
Collaborations
He has collaborated with notable colleagues such as Rob Bugel and Mitchell Gerardus Maas, contributing to advancements in their shared field of expertise.
Conclusion
Richard Henricus Christianus Eijmberts is a notable inventor whose work in intraocular lens technology has made a significant impact. His innovative methods and collaborations continue to push the boundaries of medical device technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile